Skip to content

Shakespeare in the Theatre: Shakespeare Theatre Company

Deborah C. Payne, Drew Lichtenberg
Barcode 9781350352681
Paperback

Original price £24.98 - Original price £24.98
Original price
£24.98
£24.98 - £24.98
Current price £24.98

Click here to join our rewards scheme and earn points on this purchase!

Availability:
in stock
FREE shipping

Release Date: 05/09/2024

Genre: Music Dance & Theatre
Label: The Arden Shakespeare
Series: Shakespeare in the Theatre
Contributors: Farah Karim-Cooper (Series edited by), Peter Holland (Series edited by), Stephen Purcell (Series edited by)
Language: English
Publisher: Bloomsbury Publishing PLC

This behind-the-scenes account analyzes the evolution of the premier classical theatre company in the U.S. against the changing social and economic landscape of Washington, D.C.

Co-authored by the resident dramaturg at Shakespeare Theatre Company and a long-time scholarly consultant, this book chronicles how a small repertory troupe at the Folger Theatre on Capitol Hill became an internationally renowned company performing in a lavish, multi-venue performing arts centre in downtown Washington, D.C.

The artistic vision and business acumen of Michael Kahn, the founding Artistic Director, largely catalyzed this transformation, but so too did the forces of neoliberalism and, more recently, globalization and new media. Accordingly, Shakespeare in the Theatre: Shakespeare Theatre Company not only examines directorial decision-making but also 3 decades of social and economic change in the nation’s capital, from the complexities of gentrification to the arts policies of successive administrations.

In addition to discussions of directorial practice, this book examines the ambivalence of American theatre artists toward their British cultural inheritance. Analyses of representative productions and interviews with Kahn and his British successor, Simon Godwin, illuminate this complex relationship: one that aspires to a cosmopolitan Anglophilia while positioning classically trained American actors as worthy rivals to their counterparts at the RSC and the National Theatre of Great Britain.